ReviewJournal of hematology & oncology2016
Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma.
Larysa Sanchez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
98 papers cite itlatest 60 shown
this paperpooled ittrialcites it